According to the "Peking Union Medical College Hospital Regulations on Promoting the Transformation of Scientific and Technological Achievements" (XYKF [Issue No.])2025〕43No.) stipulates thatPublic Notice on the Transformation of Scientific and Technological Achievements for "A Gene Therapy Drug Targeting RDH12 Mutations"
1. Name and Introduction of Achievements:
Result Name: A TargetedGene Therapy Drugs for RDH12 Mutations
Achievement Completers: RuiFang Sui, YunYu Zhou, Xuan Zou, QingZhang Zhou, YaMei Li, WeiXing, FengXia Yao, XiangYi Hui, RuoTian Xie
2. Proposed transaction price: RMB 1.68 million and a 5% royalty on sales
3. Price Formation Process
With the consent of the inventor and after consultation with InnoVec Biotherapeutics Inc., both parties agree to implement the transformation of this scientific and technological achievement through the transfer of patent rights.
Hereby announced, the announcement periodOn the 15th, since 202November 5, 2018From the date to202November 20, 2015Day. If there are any objections, please submit them in writing with your real name during the public announcement period.
Announcing Party: Office of Technology Transfer
Contact Number:69155708
Research Department Office of Technology Transfer
November 5, 2025